Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 2/20 | 0.65 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 3/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.54 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.54 |
| ▸ | PARP1 | P09874 | 2/20 | 0.53 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.53 |
| ▸ | PARP14 | Q460N5 | 2/20 | 0.53 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.53 |
| ▸ | CBS | P35520 | 1/20 | 0.53 |
| ▸ | MITF | O75030 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19889016 | 0.87 | TGM2 (0.66) | TGM2MEN1KMT2ARAB9ACREBBP | |
| SCHEMBL1925142 | 0.86 | KMT2A (0.71) | TGM2MEN1KMT2ANPC1RAB9A | |
| SCHEMBL4103284 | 0.85 | TGM2 (0.76) | TGM2LMNALPAR1LPAR2 | |
| SCHEMBL8686781 | 0.85 | PARP1 (0.68) | TGM2MEN1KMT2APARP1PARP15 | |
| SCHEMBL7776267 | 0.82 | TGM2 (0.57) | TGM2MEN1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL503852 | 0.82 | TGM2 (0.57) | TGM2MEN1KMT2ALMNA | |
| SCHEMBL15798246 | 0.81 | CREBBP (0.79) | LTB4RMEN1KMT2ANPC1RAB9A | |
| SCHEMBL9364431 | 0.81 | CREBBP (0.79) | LTB4RMEN1KMT2ANPC1RAB9A | |
| SCHEMBL9364423 | 0.81 | CREBBP (0.79) | LTB4RMEN1KMT2ANPC1RAB9A | |
| SCHEMBL22272087 | 0.80 | CREBBP (0.63) | LTB4RMEN1KMT2ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120059828-A | Surface-functionalized two-dimensional nanomaterial with high dispersion stability and preparation method and application thereof | 中国科学院兰州化学物理研究所 | 2025-05-30 | — | — | CN | claimed |
| CN-121950260-A | Dispersing method of nano material in nonpolar solvent, stripping and dispersing method of two-dimensional material | 中国科学院兰州化学物理研究所 | 2026-05-01 | — | — | CN | disclosed |
| CN-120059828-A | Surface-functionalized two-dimensional nanomaterial with high dispersion stability and preparation method and application thereof | 中国科学院兰州化学物理研究所 | 2025-05-30 | — | — | CN | disclosed |
| WO-2025076470-A1 | SOX10 INHIBITORS AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2025-04-10 | — | — | WO | disclosed |
| WO-2024175024-A1 | NEW FUSED HETEROCYCLIC COMPOUND AS CDKS INHIBITOR AND USE THEREOF | 杭州德睿智药科技有限公司 | 2024-08-29 | — | — | WO | disclosed |
| WO-2024125532-A1 | NOVEL HETEROCYCLIC COMPOUND ACTING AS CDKS INHIBITOR, AND USE THEREOF | 杭州德睿智药科技有限公司 | 2024-06-20 | — | — | WO | disclosed |
| WO-2023227125-A1 | NEW FUSED-HETEROCYCLIC COMPOUND AS CDK INHIBITOR AND USE THEREOF | 杭州德睿智药科技有限公司 | 2023-11-30 | — | — | WO | disclosed |
| EP-3684776-B1 | HETEROCYCLYL SUBSTITUTED PYRROLOPYRIDINES THAT ARE INHIBITORS OF THE CDK12 KINASE | UNIV NOTTINGHAM (GB) | 2023-11-01 | — | — | EP | disclosed |
| CN-112717196-B | Adhesive composition for repairing hard tissue | 嘉兴市京吟生物科技有限公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-113332486-B | Adhesive composition for hard tissue repair and kit for hard tissue repair | 嘉兴市京吟生物科技有限公司 | 2022-09-20 | — | — | CN | disclosed |
| EP-3129371-A1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | Syros Pharmaceuticals, Inc. (US) | 2017-02-15 | — | — | EP | disclosed |
| WO-2015154022-A1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | SYROS PHARMACEUTICALS, INC. (US) | 2015-10-08 | — | — | WO | disclosed |
| WO-2015154022-A1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | SYROS PHARMACEUTICALS, INC. (US) | 2015-10-08 | — | — | WO | disclosed |
| US-20120295874-A1 | COFERONS AND METHODS OF MAKING AND USING THEM | CORNELL UNIVERSITY (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120295874-A1 | COFERONS AND METHODS OF MAKING AND USING THEM | CORNELL UNIVERSITY (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120295874-A1 | COFERONS AND METHODS OF MAKING AND USING THEM | CORNELL UNIVERSITY (US) | 2012-11-22 | — | — | US | disclosed |
| EP-2485678-A1 | COFERONS AND METHODS OF MAKING AND USING THEM | Cornell University (US) | 2012-08-15 | — | — | EP | disclosed |
| WO-2011043817-A1 | COFERONS AND METHODS OF MAKING AND USING THEM | CORNELL UNIVERSITY (US) | 2011-04-14 | — | — | WO | disclosed |
| WO-2011043817-A1 | COFERONS AND METHODS OF MAKING AND USING THEM | CORNELL UNIVERSITY (US) | 2011-04-14 | — | — | WO | disclosed |
| US-5719151-A | PHTHALAZINEDIONE COMPOUND; POLYMERASE INHIBITOR | SHALL SYDNEY (GB) | 1998-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120295874-A1 | COFERONS AND METHODS OF MAKING AND USING THEM | MYOF, FTH1, HCCS | TGM2 2876/4885LTB4R 2583/4885MEN1 1112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.